FGFR2 and gastric cancer: Indeed, this analysis showed that patients with diffuse-type GC presenting high FGFR2-IIIc expression had a significantly worse overall survival (Figure 4b,c, overall log-rank p-value = 3.40 × 10−2, for all comparisons see Figure S6a).